Jennison Associates LLC Repligen Corp Transaction History

Jennison Associates LLC

$160 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$140.68 - $188.02 $503,915 - $673,487	-3,582 Reduced 4.47%	76,573 $12.4 Million
Q1 2022 May 11, 2022	SELL	$161.19 - $257.96 $1.49 Million - $2.39 Million	-9,255 Reduced 10.35%	80,155 $15.1 Million
Q4 2021 Feb 08, 2022	BUY	$247.59 - $304.47 $947,774 - $1.17 Million	3,828 Added 4.47%	89,410 $23.7 Million
Q3 2021 Nov 09, 2021	BUY	$194.77 - $324.21 $574,181 - $955,771	2,948 Added 3.57%	85,582 $24.7 Million
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $18.3 Million - $24.4 Million	-110,359 Reduced 57.18%	82,634 $16.5 Million
Q1 2021 May 11, 2021	SELL	$180.37 - $226.26 $314,024 - $393,918	-1,741 Reduced 0.89%	192,993 $37.5 Million
Q4 2020 Feb 05, 2021	SELL	$148.08 - $206.57 $292,458 - $407,975	-1,975 Reduced 1.0%	194,734 $37.3 Million
Q3 2020 Nov 04, 2020	BUY	$122.51 - $158.27 $96,660 - $124,875	789 Added 0.4%	196,709 $29 Million
Q2 2020 Aug 06, 2020	BUY	$94.33 - $140.48 $114,044 - $169,840	1,209 Added 0.62%	195,920 $24.2 Million
Q1 2020 May 06, 2020	BUY	$84.96 - $109.14 $144,007 - $184,992	1,695 Added 0.88%	194,711 $18.8 Million
Q4 2019 Feb 07, 2020	BUY	$73.84 - $93.08 $128,998 - $162,610	1,747 Added 0.91%	193,016 $17.9 Million
Q3 2019 Nov 08, 2019	SELL	$76.65 - $95.51 $1.48 Million - $1.84 Million	-19,300 Reduced 9.17%	191,269 $14.7 Million
Q2 2019 Aug 06, 2019	SELL	$54.2 - $85.95 $23,848 - $37,818	-440 Reduced 0.21%	210,569 $0
Q1 2019 May 10, 2019	SELL	$49.45 - $62.8 $2,373 - $3,014	-48 Reduced 0.02%	211,009 $12.5 Million
Q4 2018 Feb 06, 2019	BUY	$48.26 - $68.88 $114,231 - $163,038	2,367 Added 1.13%	211,057 $11.1 Million
Q3 2018 Nov 08, 2018	BUY	$46.8 - $58.97 $88,264 - $111,217	1,886 Added 0.91%	208,690 $11.6 Million
Q2 2018 Aug 02, 2018	BUY	$35.26 - $47.04 $6.44 Million - $8.59 Million	182,562 Added 753.08%	206,804 $9.73 Million
Q1 2018 Apr 20, 2018	BUY	$30.92 - $37.27 $749,562 - $903,499	24,242 New	24,242 $877,000

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.4M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$944 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$797 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$629 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$203 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$177 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account